Pathway Markers for Pro-resolving Lipid Mediators in Maternal and Umbilical Cord Blood: A Secondary Analysis of the Mothers, Omega-3, and Mental Health Study
The omega-3 fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) are precursors to immune regulatory and specialized pro-resolving mediators (SPM) of inflammation termed resolvins, maresins, and protectins. Evidence for lipid mediator formation in vivo can be gained through evaluat...
Gespeichert in:
| Veröffentlicht in: | Frontiers in pharmacology Jg. 7; S. 274 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
Switzerland
Frontiers Media S.A
07.09.2016
|
| Schlagworte: | |
| ISSN: | 1663-9812, 1663-9812 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | The omega-3 fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) are precursors to immune regulatory and specialized pro-resolving mediators (SPM) of inflammation termed resolvins, maresins, and protectins. Evidence for lipid mediator formation in vivo can be gained through evaluation of their 5-lipoxygenase (LOX) and 15-LOX metabolic pathway precursors and downstream metabolites. We performed a secondary blood sample analysis from 60 participants in the Mothers, Omega-3, and Mental Health study to determine whether SPM and SPM precursors are augmented by dietary EPA- and DHA-rich fish oil supplementation compared to soy oil placebo. We also aimed to study whether SPM and their precursors differ in early and late pregnancy or between maternal and umbilical cord blood. We found that compared to placebo supplementation, EPA- and DHA-rich fish oil supplementation increased SPM precursor 17-hydroxy docosahexaenoic acid (17-HDHA) concentrations in maternal and umbilical cord blood (P = 0.02). We found that the D-series resolvin pathway marker 17-HDHA increased significantly between enrollment and late pregnancy (P = 0.049). Levels of both 14-HDHA, a maresin pathway marker, and 17-HDHA were significantly greater in umbilical cord blood than in maternal blood (P < 0.001, both). |
|---|---|
| AbstractList | The omega-3 fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) are precursors to immune regulatory and specialized pro-resolving mediators (SPM) of inflammation termed resolvins, maresins, and protectins. Evidence for lipid mediator formation in vivo can be gained through evaluation of their 5-lipoxygenase (LOX) and 15-LOX metabolic pathway precursors and downstream metabolites. We performed a secondary blood sample analysis from 60 participants in the Mothers, Omega-3, and Mental Health study to determine whether SPM and SPM precursors are augmented by dietary EPA- and DHA-rich fish oil supplementation compared to soy oil placebo. We also aimed to study whether SPM and their precursors differ in early and late pregnancy or between maternal and umbilical cord blood. We found that compared to placebo supplementation, EPA- and DHA-rich fish oil supplementation increased SPM precursor 17-hydroxy docosahexaenoic acid (17-HDHA) concentrations in maternal and umbilical cord blood (P = 0.02). We found that the D-series resolvin pathway marker 17-HDHA increased significantly between enrollment and late pregnancy (P = 0.049). Levels of both 14-HDHA, a maresin pathway marker, and 17-HDHA were significantly greater in umbilical cord blood than in maternal blood (P < 0.001, both). The omega-3 fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) are precursors to immune regulatory and specialized pro-resolving mediators (SPM) of inflammation termed resolvins, maresins, and protections. Evidence for lipid mediator formation in vivo can be gained through evaluation of their 5-lipoxygenase (LOX) and 15-LOX metabolic pathway precursors and downstream metabolites: We performed a secondary blood sample analysis from 60 participants in the Mothers, Omega-3, and Mental Health study to determine whether SPM and SPM precursors are augmented by dietary EPA- and DHA-rich fish oil supplementation compared to soy oil placebo. We also aimed to study whether SPM and their precursors differ in early and late pregnancy or between maternal and umbilical cord blood. We found that compared to placebo supplementation, EPA- and DHA- rich fish oil supplementation increased SPM precursor 17-HDHA concentrations in maternal and umbilical cord blood (P=0.02) We found that the D-series resolvin pathway marker 17-HDHA increased significantly between enrollment and late pregnancy (P=0.049). Levels of both 14-HDHA, a maresin pathway marker, and 17-HDHA were significantly greater in umbilical cord blood than in maternal blood (P<0.001, both). The omega-3 fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) are precursors to immune regulatory and specialized pro-resolving mediators (SPM) of inflammation termed resolvins, maresins, and protectins. Evidence for lipid mediator formation in vivo can be gained through evaluation of their 5-lipoxygenase (LOX) and 15-LOX metabolic pathway precursors and downstream metabolites. We performed a secondary blood sample analysis from 60 participants in the Mothers, Omega-3, and Mental Health study to determine whether SPM and SPM precursors are augmented by dietary EPA- and DHA-rich fish oil supplementation compared to soy oil placebo. We also aimed to study whether SPM and their precursors differ in early and late pregnancy or between maternal and umbilical cord blood. We found that compared to placebo supplementation, EPA- and DHA-rich fish oil supplementation increased SPM precursor 17-hydroxy docosahexaenoic acid (17-HDHA) concentrations in maternal and umbilical cord blood (P = 0.02). We found that the D-series resolvin pathway marker 17-HDHA increased significantly between enrollment and late pregnancy (P = 0.049). Levels of both 14-HDHA, a maresin pathway marker, and 17-HDHA were significantly greater in umbilical cord blood than in maternal blood (P < 0.001, both).The omega-3 fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) are precursors to immune regulatory and specialized pro-resolving mediators (SPM) of inflammation termed resolvins, maresins, and protectins. Evidence for lipid mediator formation in vivo can be gained through evaluation of their 5-lipoxygenase (LOX) and 15-LOX metabolic pathway precursors and downstream metabolites. We performed a secondary blood sample analysis from 60 participants in the Mothers, Omega-3, and Mental Health study to determine whether SPM and SPM precursors are augmented by dietary EPA- and DHA-rich fish oil supplementation compared to soy oil placebo. We also aimed to study whether SPM and their precursors differ in early and late pregnancy or between maternal and umbilical cord blood. We found that compared to placebo supplementation, EPA- and DHA-rich fish oil supplementation increased SPM precursor 17-hydroxy docosahexaenoic acid (17-HDHA) concentrations in maternal and umbilical cord blood (P = 0.02). We found that the D-series resolvin pathway marker 17-HDHA increased significantly between enrollment and late pregnancy (P = 0.049). Levels of both 14-HDHA, a maresin pathway marker, and 17-HDHA were significantly greater in umbilical cord blood than in maternal blood (P < 0.001, both). |
| Author | Gronert, Karsten Mozurkewich, Ellen L. Greenwood, Matthew Djuric, Zora Clinton, Chelsea Romero, Vivian Berman, Deborah Qualls, Clifford |
| AuthorAffiliation | 4 Obstetrics of Gynecology, Duke University Durham, NC, USA 1 Obstetrics and Gynecology, University of New Mexico Albuquerque, NM, USA 3 Vision Science Program, Infectious Diseases and Immunity Program, School of Optometry, University of California at Berkeley Berkeley, CA, USA 5 Obstetrics and Gynecology, Michigan State University Grand Rapids, MI, USA 2 Obstetrics and Gynecology, University of Michigan Ann Arbor, MI, USA 6 Family Medicine, University of Michigan Ann Arbor, MI, USA 7 Clinical and Translational Sciences Center, University of New Mexico Albuquerque, NM, USA |
| AuthorAffiliation_xml | – name: 7 Clinical and Translational Sciences Center, University of New Mexico Albuquerque, NM, USA – name: 2 Obstetrics and Gynecology, University of Michigan Ann Arbor, MI, USA – name: 6 Family Medicine, University of Michigan Ann Arbor, MI, USA – name: 1 Obstetrics and Gynecology, University of New Mexico Albuquerque, NM, USA – name: 4 Obstetrics of Gynecology, Duke University Durham, NC, USA – name: 5 Obstetrics and Gynecology, Michigan State University Grand Rapids, MI, USA – name: 3 Vision Science Program, Infectious Diseases and Immunity Program, School of Optometry, University of California at Berkeley Berkeley, CA, USA |
| Author_xml | – sequence: 1 givenname: Ellen L. surname: Mozurkewich fullname: Mozurkewich, Ellen L. – sequence: 2 givenname: Matthew surname: Greenwood fullname: Greenwood, Matthew – sequence: 3 givenname: Chelsea surname: Clinton fullname: Clinton, Chelsea – sequence: 4 givenname: Deborah surname: Berman fullname: Berman, Deborah – sequence: 5 givenname: Vivian surname: Romero fullname: Romero, Vivian – sequence: 6 givenname: Zora surname: Djuric fullname: Djuric, Zora – sequence: 7 givenname: Clifford surname: Qualls fullname: Qualls, Clifford – sequence: 8 givenname: Karsten surname: Gronert fullname: Gronert, Karsten |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27656142$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kstuEzEUhkeoiJbSPSvkJYtO8NgznhkWSCECWilRK5WuLV-OMy7OONhOUR6Gd8VJStUi4YWv__nOsf2_Lo5GP0JRvK3whNKu_2DWgwgTgis2wZi09YvipGKMln1XkaMn8-PiLMY7nBvte8rqV8UxaVnDqpqcFL-vRRp-iS1aiPADQkTGB3QdfBkgendvxyWa27XVaAHaiuSzwo5ZnCCMwiExanS7ktZZlVczHzT67LzXH9EU3YDyoxZhi6ZZuo02Im9QGgAtfO5DPEdXK1iKkp7vOQsYU4ZcgHBpQDdpo7dvipdGuAhnD-Npcfv1y_fZRTm_-nY5m85LVTOSSqm0JEbT3vQSt63RvVGm7rTULYAyuiOV0VpTDFLrvq2FoW1bCcJ6obpWV_S0uDxwtRd3fB3sKpfNvbB8v-HDkouQrHLAcddJJvL7GxB1h5VkrG8w7RpQmoKUmfXpwFpv5Aq0yrcKwj2DPj8Z7cCX_p43uKKkYRnw_gEQ_M8NxMRXNipwTozgN5FXHaGY1k3dZum7p7kek_z93yzAB4EKPsYA5lFSYb5zEd-7iO9cxPcuyiHsnxBlk0jW76q17v-BfwDNLNB6 |
| CitedBy_id | crossref_primary_10_3390_nu11010098 crossref_primary_10_3390_nu12113384 crossref_primary_10_3390_life12040526 crossref_primary_10_3390_biomedicines11010171 crossref_primary_10_3390_nu17122014 crossref_primary_10_3390_ijms241311012 crossref_primary_10_1016_j_mam_2017_03_007 crossref_primary_10_3390_molecules30020281 crossref_primary_10_1016_j_clnesp_2023_06_011 crossref_primary_10_1016_j_mam_2017_03_005 crossref_primary_10_3390_nu14081662 crossref_primary_10_1016_j_plefa_2017_09_017 crossref_primary_10_1080_14728222_2019_1599360 crossref_primary_10_20960_nh_04523 crossref_primary_10_1016_j_prostaglandins_2022_106648 crossref_primary_10_3390_ijms23020708 crossref_primary_10_1016_j_mam_2017_08_002 crossref_primary_10_1172_JCI97943 crossref_primary_10_3390_ijms242216143 crossref_primary_10_3390_nu15204340 crossref_primary_10_1016_j_tjnut_2025_01_012 crossref_primary_10_3390_nu13030834 crossref_primary_10_1016_j_prostaglandins_2023_106718 crossref_primary_10_3390_nu13010247 crossref_primary_10_1038_s41598_018_36679_4 crossref_primary_10_1016_j_plefa_2025_102682 crossref_primary_10_1016_j_plipres_2022_101165 crossref_primary_10_1016_j_plipres_2020_101082 crossref_primary_10_3389_fimmu_2024_1377236 crossref_primary_10_3390_ijms20184402 crossref_primary_10_1016_j_gastha_2022_02_007 crossref_primary_10_1096_fj_201601222R crossref_primary_10_1016_j_mce_2021_111466 crossref_primary_10_1111_bph_13971 crossref_primary_10_1016_j_plefa_2017_05_003 crossref_primary_10_1016_j_bbalip_2018_11_012 crossref_primary_10_1016_j_anai_2018_12_008 crossref_primary_10_1016_j_bbalip_2025_159629 |
| Cites_doi | 10.1152/ajpcell.00024.2014 10.1016/j.prostaglandins.2012.01.005 10.1001/jama.2010.1507 10.1079/BJN20051631 10.1126/scitranslmed.3001571 10.1021/cr100396c 10.1186/1476-511X-12-89 10.1152/ajpgi.00106.2013 10.1016/j.prostaglandins.2010.12.006 10.1017/S0007114507709078 10.1194/jlr.M039842 10.1038/srep03113 10.1093/ajcn/83.6.1337 10.1161/JAHA.115.002034 10.1042/BJ20110327 10.1530/REP-14-0549 10.1016/j.jaci.2012.07.048 10.1016/j.ajog.2013.01.038 10.1194/jlr.M060392 10.1016/j.clnu.2015.04.004 10.1016/j.plefa.2015.05.003 10.1371/journal.pone.0055859 10.1016/j.smim.2015.03.004 10.1038/nature11351 10.1194/jlr.M045583 10.1371/journal.pone.0026877 10.1096/fj.10-178657 10.4049/jimmunol.0802064 10.1124/mi.8.1.7 10.1073/pnas.1000373107 10.1194/jlr.C062356 10.1002/14651858.CD003402 10.1371/journal.pone.0016957 10.1038/nature13479 10.1096/fj.06-6250fje 10.1096/fj.08-125674 |
| ContentType | Journal Article |
| Copyright | Copyright © 2016 Mozurkewich, Greenwood, Clinton, Berman, Romero, Djuric, Qualls and Gronert. 2016 Mozurkewich, Greenwood, Clinton, Berman, Romero, Djuric, Qualls and Gronert |
| Copyright_xml | – notice: Copyright © 2016 Mozurkewich, Greenwood, Clinton, Berman, Romero, Djuric, Qualls and Gronert. 2016 Mozurkewich, Greenwood, Clinton, Berman, Romero, Djuric, Qualls and Gronert |
| DBID | AAYXX CITATION NPM 7X8 5PM DOA |
| DOI | 10.3389/fphar.2016.00274 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1663-9812 |
| ExternalDocumentID | oai_doaj_org_article_088b6a389fea480cb66950385ecd3ebb PMC5013256 27656142 10_3389_fphar_2016_00274 |
| Genre | Journal Article |
| GrantInformation_xml | – fundername: NEI NIH HHS grantid: R01 EY026082 – fundername: NCI NIH HHS grantid: P30 CA046592 – fundername: NCATS NIH HHS grantid: UL1 TR001449 – fundername: NCCIH NIH HHS grantid: R21 AT004166 – fundername: NEI NIH HHS grantid: R01 EY022208 – fundername: National Institutes of Health grantid: R21 AT004166-03S1 (NCCAM), |
| GroupedDBID | 53G 5VS 9T4 AAFWJ AAKDD AAYXX ACGFO ACGFS ADBBV ADRAZ AENEX AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK EMOBN GROUPED_DOAJ GX1 HYE KQ8 M48 M~E O5R O5S OK1 P2P PGMZT RNS RPM ACXDI IPNFZ NPM RIG 7X8 5PM |
| ID | FETCH-LOGICAL-c462t-bcdb2fd39f9b077fd9fcf48dbd7eecfd821fddd30ebdd974af3771a269ac87d13 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 41 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000382515900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1663-9812 |
| IngestDate | Fri Oct 03 12:50:49 EDT 2025 Tue Sep 30 16:43:31 EDT 2025 Fri Sep 05 09:38:00 EDT 2025 Thu Apr 03 07:08:44 EDT 2025 Tue Nov 18 22:42:26 EST 2025 Sat Nov 29 03:41:16 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | DHA resolvins EPA |
| Language | English |
| License | This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c462t-bcdb2fd39f9b077fd9fcf48dbd7eecfd821fddd30ebdd974af3771a269ac87d13 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 This article was submitted to Obstetric and Pediatric Pharmacology, a section of the journal Frontiers in Pharmacology Reviewed by: Karin A. Fox, Baylor College of Medicine, USA; Azadeh Farzin, Johns Hopkins University, USA Edited by: Irina Burd, Johns Hopkins School of Medicine, USA |
| OpenAccessLink | https://doaj.org/article/088b6a389fea480cb66950385ecd3ebb |
| PMID | 27656142 |
| PQID | 1823034547 |
| PQPubID | 23479 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_088b6a389fea480cb66950385ecd3ebb pubmedcentral_primary_oai_pubmedcentral_nih_gov_5013256 proquest_miscellaneous_1823034547 pubmed_primary_27656142 crossref_primary_10_3389_fphar_2016_00274 crossref_citationtrail_10_3389_fphar_2016_00274 |
| PublicationCentury | 2000 |
| PublicationDate | 2016-09-07 |
| PublicationDateYYYYMMDD | 2016-09-07 |
| PublicationDate_xml | – month: 09 year: 2016 text: 2016-09-07 day: 07 |
| PublicationDecade | 2010 |
| PublicationPlace | Switzerland |
| PublicationPlace_xml | – name: Switzerland |
| PublicationTitle | Frontiers in pharmacology |
| PublicationTitleAlternate | Front Pharmacol |
| PublicationYear | 2016 |
| Publisher | Frontiers Media S.A |
| Publisher_xml | – name: Frontiers Media S.A |
| References | Pruss (B25) 2013; 8 Hellmann (B13) 2011; 25 Gonzalez (B7) 2011; 6 Keelan (B17) 2015; 149 Serhan (B30) 2011; 111 Delarue (B4) 2006; 95 Horvath (B14) 2007; 98 Jones (B15) 2013; 54 Baack (B1) 2015; 100 Murphy (B24) 2015; 56 Morris (B22) 2010; 107 Sapieha (B27) 2011; 3 Weylandt (B35) 2012; 97 Colas (B3) 2014; 307 Gomolka (B6) 2011; 94 Psychogios (B26) 2011; 6 Kalish (B16) 2013; 305 Serhan (B28) 2014; 510 Mozurkewich (B23) 2013; 208 Mas (B20) 2016; 35 Gonzalez-Periz (B9) 2006; 20 Barden (B2) 2014; 55 Weiss (B34) 2013; 12 González-Périz (B8) 2009; 23 von Moltke (B33) 2012; 490 Szajewska (B32) 2006; 83 Makrides (B19) 2010; 304 Grenon (B10) 2015; 4 Fredman (B5) 2011; 437 Gronert (B11) 2008; 8 Makrides (B18) 2006; 3 Miyata (B21) 2013; 131 Serhan (B29) 2015; 27 Skarke (B31) 2015; 56 Yamashita (B36) 2013; 3 Hassan (B12) 2009; 182 22326554 - Prostaglandins Other Lipid Mediat. 2012 Mar;97(3-4):73-82 23409068 - PLoS One. 2013;8(2):e55859 18332482 - Mol Interv. 2008 Feb;8(1):28-35 23006546 - J Allergy Clin Immunol. 2013 Feb;131(2):353-60.e1-2 21711247 - Biochem J. 2011 Jul 15;437(2):185-97 16762945 - Am J Clin Nutr. 2006 Jun;83(6):1337-44 20421472 - Proc Natl Acad Sci U S A. 2010 May 11;107(19):8842-7 24899309 - Nature. 2014 Jun 5;510(7503):92-101 23723388 - J Lipid Res. 2013 Aug;54(8):2247-54 16856006 - Cochrane Database Syst Rev. 2006 Jul 19;(3):CD003402 25857211 - Semin Immunol. 2015 May;27(3):200-15 22902502 - Nature. 2012 Oct 4;490(7418):107-11 26232500 - J Lipid Res. 2015 Sep;56(9):1641-2 19211925 - FASEB J. 2009 Jun;23(6):1946-57 16469141 - Br J Nutr. 2006 Feb;95(2):267-72 23767972 - Lipids Health Dis. 2013 Jun 15;12:89 19234220 - J Immunol. 2009 Mar 1;182(5):3223-32 23531328 - Am J Obstet Gynecol. 2013 Apr;208(4):313.e1-9 22073213 - PLoS One. 2011;6(11):e26877 25187667 - J Lipid Res. 2014 Nov;55(11):2401-7 17419889 - Br J Nutr. 2007 Aug;98(2):253-9 21236358 - Prostaglandins Other Lipid Mediat. 2011 Apr;94(3-4):81-7 21359215 - PLoS One. 2011 Feb 16;6(2):e16957 26180051 - J Lipid Res. 2015 Sep;56(9):1808-20 24696140 - Am J Physiol Cell Physiol. 2014 Jul 1;307(1):C39-54 20959577 - JAMA. 2010 Oct 20;304(15):1675-83 24091595 - Am J Physiol Gastrointest Liver Physiol. 2013 Dec;305(11):G818-28 26296857 - J Am Heart Assoc. 2015 Aug 21;4(8):e002034 17056761 - FASEB J. 2006 Dec;20(14 ):2537-9 21478260 - FASEB J. 2011 Jul;25(7):2399-407 24177907 - Sci Rep. 2013 Nov 01;3:3113 25908532 - Clin Nutr. 2016 Apr;35(2):331-6 21307302 - Sci Transl Med. 2011 Feb 9;3(69):69ra12 26205427 - Prostaglandins Leukot Essent Fatty Acids. 2015 Sep;100:5-11 21766791 - Chem Rev. 2011 Oct 12;111(10):5922-43 25504868 - Reproduction. 2015 Feb;149(2):171-8 |
| References_xml | – volume: 307 start-page: C39 year: 2014 ident: B3 article-title: Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue. publication-title: Am. J. Physiol. Cell Physiol. doi: 10.1152/ajpcell.00024.2014 – volume: 97 start-page: 73 year: 2012 ident: B35 article-title: Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation. publication-title: Prostaglandins Other Lipid Mediat. doi: 10.1016/j.prostaglandins.2012.01.005 – volume: 304 start-page: 1675 year: 2010 ident: B19 article-title: Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. publication-title: JAMA doi: 10.1001/jama.2010.1507 – volume: 95 start-page: 267 year: 2006 ident: B4 article-title: Interaction of fish oil and a glucocorticoid on metabolic responses to an oral glucose load in healthy human subjects. publication-title: Br. J. Nutr. doi: 10.1079/BJN20051631 – volume: 3 issue: 69ra12 year: 2011 ident: B27 article-title: 5-Lipoxygenase metabolite 4-HDHA Is a mediator of the antiangiogenic effect of ω-3 polyunsaturated fatty acids. publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.3001571 – volume: 111 start-page: 5922 year: 2011 ident: B30 article-title: Resolvins and protectins in inflammation resolution. publication-title: Chem. Rev. doi: 10.1021/cr100396c – volume: 12 issue: 89 year: 2013 ident: B34 article-title: High levels of anti-inflammatory and pro-resolving lipid mediators lipoxins and resolvins and declining docosahexaenoic acid levels in human milk during the first month of lactation. publication-title: Lipids Health. Dis. doi: 10.1186/1476-511X-12-89 – volume: 305 start-page: G818 year: 2013 ident: B16 article-title: Intravenous fish oil lipid emulsion promotes a shift toward anti-inflammatory pro-resolving lipid mediators. publication-title: Am. J. Physiol. Gastrointest. Liver Physiol. doi: 10.1152/ajpgi.00106.2013 – volume: 94 start-page: 81 year: 2011 ident: B6 article-title: Analysis of omega-3 and omega-6 fatty acid-derived lipid metabolite formation in human and mouse blood samples. publication-title: Prostaglandins Other Lipid Mediat. doi: 10.1016/j.prostaglandins.2010.12.006 – volume: 98 start-page: 253 year: 2007 ident: B14 article-title: Effect of supplementation of women in high-risk pregnancies with long-chain polyunsaturated fatty acids on pregnancy outcomes and growth measures at birth: a meta-analysis of randomized controlled trials. publication-title: Br. J. Nutr. doi: 10.1017/S0007114507709078 – volume: 54 start-page: 2247 year: 2013 ident: B15 article-title: Maternal dietary omega-3 fatty acid intake increases resolvin and protectin levels in the rat placenta. publication-title: J. Lipid Res. doi: 10.1194/jlr.M039842 – volume: 3 issue: 3113 year: 2013 ident: B36 article-title: Increased tissue levels of omega-3 polyunsaturated fatty acids prevents pathological preterm birth. publication-title: Sci. Rep. doi: 10.1038/srep03113 – volume: 83 start-page: 1337 year: 2006 ident: B32 article-title: Effect of n-3 long-chain polyunsaturated fatty acid supplementation of women with low-risk pregnancies on pregnancy outcomes and growth measures at birth: a meta-analysis of randomized controlled trials. publication-title: Am. J. Clin. Nutr. doi: 10.1093/ajcn/83.6.1337 – volume: 4 issue: e002034 year: 2015 ident: B10 article-title: Short-Term, high-dose fish oil supplementation increases the production of omega-3 fatty acid-derived mediators in patients with peripheral artery disease (the OMEGA-PAD I Trial). publication-title: J. Am. Heart Assoc. doi: 10.1161/JAHA.115.002034 – volume: 437 start-page: 185 year: 2011 ident: B5 article-title: Specialized pro-resolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution. publication-title: Biochem. J. doi: 10.1042/BJ20110327 – volume: 149 start-page: 171 year: 2015 ident: B17 article-title: Effects of maternal n-3 fatty acid supplementation on placental cytokines, pro-resolving lipid mediators and their precursors. publication-title: Reproduction doi: 10.1530/REP-14-0549 – volume: 131 start-page: 353 year: 2013 ident: B21 article-title: Dysregulated synthesis of protectin D1 in eosinophils from patients with severe asthma. publication-title: J. Allergy Clin. Immunol. doi: 10.1016/j.jaci.2012.07.048 – volume: 208 issue: 313 year: 2013 ident: B23 article-title: The mothers, omega-3, and mental health study: a double-blind, randomized controlled trial. publication-title: Am. J. Obstet. Gynecol. doi: 10.1016/j.ajog.2013.01.038 – volume: 56 start-page: 1808 year: 2015 ident: B31 article-title: Bioactive products formed in humans from fish oils. publication-title: J. Lipid Res. doi: 10.1194/jlr.M060392 – volume: 35 start-page: 331 year: 2016 ident: B20 article-title: A randomized controlled trial of the effects of n-3 fatty acids on resolvins in chronic kidney disease. publication-title: Clin. Nutr. doi: 10.1016/j.clnu.2015.04.004 – volume: 100 start-page: 5 year: 2015 ident: B1 article-title: What is the relationship between gestational age and docosahexaenoic acid (DHA) and arachidonic acid (ARA) levels? publication-title: Prostaglandins Leukot. Essent. Fatty Acids doi: 10.1016/j.plefa.2015.05.003 – volume: 8 issue: e55859 year: 2013 ident: B25 article-title: Proresolution lipid mediators in multiple sclerosis - differential, disease severity-dependent synthesis - a clinical pilot trial. publication-title: PLoS ONE doi: 10.1371/journal.pone.0055859 – volume: 27 start-page: 200 year: 2015 ident: B29 article-title: The resolution code of acute inflammation: novel pro-resolving lipid mediators in resolution. publication-title: Semin. Immunol. doi: 10.1016/j.smim.2015.03.004 – volume: 490 start-page: 107 year: 2012 ident: B33 article-title: Rapid induction of inflammatory lipid mediators by the inflammasome in vivo. publication-title: Nature doi: 10.1038/nature11351 – volume: 55 start-page: 2401 year: 2014 ident: B2 article-title: Short-term n-3 fatty acid supplementation but not aspirin increases plasma pro-resolving mediators of inflammation. publication-title: J. Lipid Res. doi: 10.1194/jlr.M045583 – volume: 6 issue: e26877 year: 2011 ident: B7 article-title: Cervical remodeling/ripening at term and preterm delivery: the same mechanism initiated by different mediators and different effector cells. publication-title: PLoS ONE doi: 10.1371/journal.pone.0026877 – volume: 25 start-page: 2399 year: 2011 ident: B13 article-title: Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice. publication-title: FASEB J. doi: 10.1096/fj.10-178657 – volume: 182 start-page: 3223 year: 2009 ident: B12 article-title: Acute changes in dietary omega-3 and omega-6 polyunsaturated fatty acids have a pronounced impact on survival following ischemic renal injury and formation of renoprotective docosahexaenoic acid-derived protectin D1. publication-title: J. Immunol. doi: 10.4049/jimmunol.0802064 – volume: 8 start-page: 28 year: 2008 ident: B11 article-title: Lipid autacoids in inflammation and injury responses: a matter of privilege. publication-title: Mol. Interv. doi: 10.1124/mi.8.1.7 – volume: 107 start-page: 8842 year: 2010 ident: B22 article-title: Dichotomy in duration and severity of acute inflammatory responses in humans arising from differentially expressed proresolution pathways. publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.1000373107 – volume: 56 start-page: 1641 year: 2015 ident: B24 article-title: Specialized pro-resolving mediators: do they circulate in plasma? publication-title: J. Lipid Res. doi: 10.1194/jlr.C062356 – volume: 3 issue: CD003402 year: 2006 ident: B18 article-title: Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restriction. publication-title: Cochrane Database Syst. Rev. doi: 10.1002/14651858.CD003402 – volume: 6 issue: e16957 year: 2011 ident: B26 article-title: The human serum metabolome. publication-title: PLoS ONE doi: 10.1371/journal.pone.0016957 – volume: 510 start-page: 92 year: 2014 ident: B28 article-title: Pro-resolving lipid mediators are leads for resolution physiology. publication-title: Nature doi: 10.1038/nature13479 – volume: 20 start-page: 2537 year: 2006 ident: B9 article-title: Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S-hydroxy-DHA. publication-title: FASEB J. doi: 10.1096/fj.06-6250fje – volume: 23 start-page: 1946 year: 2009 ident: B8 article-title: Obesity-induced insulin resistance and hepatic steatosis are alleviated by ω-3 fatty acids: a role for resolvins and protectins. publication-title: FASEB J. doi: 10.1096/fj.08-125674 – reference: 21359215 - PLoS One. 2011 Feb 16;6(2):e16957 – reference: 26296857 - J Am Heart Assoc. 2015 Aug 21;4(8):e002034 – reference: 24899309 - Nature. 2014 Jun 5;510(7503):92-101 – reference: 16856006 - Cochrane Database Syst Rev. 2006 Jul 19;(3):CD003402 – reference: 21307302 - Sci Transl Med. 2011 Feb 9;3(69):69ra12 – reference: 17419889 - Br J Nutr. 2007 Aug;98(2):253-9 – reference: 26180051 - J Lipid Res. 2015 Sep;56(9):1808-20 – reference: 26205427 - Prostaglandins Leukot Essent Fatty Acids. 2015 Sep;100:5-11 – reference: 23531328 - Am J Obstet Gynecol. 2013 Apr;208(4):313.e1-9 – reference: 21711247 - Biochem J. 2011 Jul 15;437(2):185-97 – reference: 24696140 - Am J Physiol Cell Physiol. 2014 Jul 1;307(1):C39-54 – reference: 18332482 - Mol Interv. 2008 Feb;8(1):28-35 – reference: 23767972 - Lipids Health Dis. 2013 Jun 15;12:89 – reference: 16762945 - Am J Clin Nutr. 2006 Jun;83(6):1337-44 – reference: 22902502 - Nature. 2012 Oct 4;490(7418):107-11 – reference: 23409068 - PLoS One. 2013;8(2):e55859 – reference: 23723388 - J Lipid Res. 2013 Aug;54(8):2247-54 – reference: 23006546 - J Allergy Clin Immunol. 2013 Feb;131(2):353-60.e1-2 – reference: 25857211 - Semin Immunol. 2015 May;27(3):200-15 – reference: 25908532 - Clin Nutr. 2016 Apr;35(2):331-6 – reference: 25187667 - J Lipid Res. 2014 Nov;55(11):2401-7 – reference: 16469141 - Br J Nutr. 2006 Feb;95(2):267-72 – reference: 20421472 - Proc Natl Acad Sci U S A. 2010 May 11;107(19):8842-7 – reference: 19234220 - J Immunol. 2009 Mar 1;182(5):3223-32 – reference: 19211925 - FASEB J. 2009 Jun;23(6):1946-57 – reference: 20959577 - JAMA. 2010 Oct 20;304(15):1675-83 – reference: 21236358 - Prostaglandins Other Lipid Mediat. 2011 Apr;94(3-4):81-7 – reference: 21478260 - FASEB J. 2011 Jul;25(7):2399-407 – reference: 24091595 - Am J Physiol Gastrointest Liver Physiol. 2013 Dec;305(11):G818-28 – reference: 25504868 - Reproduction. 2015 Feb;149(2):171-8 – reference: 21766791 - Chem Rev. 2011 Oct 12;111(10):5922-43 – reference: 17056761 - FASEB J. 2006 Dec;20(14 ):2537-9 – reference: 24177907 - Sci Rep. 2013 Nov 01;3:3113 – reference: 26232500 - J Lipid Res. 2015 Sep;56(9):1641-2 – reference: 22073213 - PLoS One. 2011;6(11):e26877 – reference: 22326554 - Prostaglandins Other Lipid Mediat. 2012 Mar;97(3-4):73-82 |
| SSID | ssj0000399364 |
| Score | 2.2841544 |
| Snippet | The omega-3 fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) are precursors to immune regulatory and specialized pro-resolving mediators... |
| SourceID | doaj pubmedcentral proquest pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 274 |
| SubjectTerms | DHA EPA markers Pathway Pharmacology Resolvins |
| Title | Pathway Markers for Pro-resolving Lipid Mediators in Maternal and Umbilical Cord Blood: A Secondary Analysis of the Mothers, Omega-3, and Mental Health Study |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/27656142 https://www.proquest.com/docview/1823034547 https://pubmed.ncbi.nlm.nih.gov/PMC5013256 https://doaj.org/article/088b6a389fea480cb66950385ecd3ebb |
| Volume | 7 |
| WOSCitedRecordID | wos000382515900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1663-9812 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000399364 issn: 1663-9812 databaseCode: DOA dateStart: 20100101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1663-9812 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000399364 issn: 1663-9812 databaseCode: M~E dateStart: 20100101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9NADB7BigMXxJsusDISWgmpUfOehNuCdsWBXSqxSL1FM-MZNlKbVn2AeuF_8G-xZ7rdFiG4cMkhcRRr7PHYsf1ZiNdSWlcWtYlsITHKMdWRpkgriitFL-gYK-cl_VFeXFSjUT3cGfXFNWEBHjgs3IB2gS4VHavOqryKjS7LmiFMCmsws1qz9Y1lvRNMeRvM526Zh7wkRWH1wM2uFON_Jpx8SGW-dw55uP4_-Zi_l0runD1n98W9jdMIJ4HZB-KW7R6K42FAnV734fKmiWrRh2MY3uBRrx-Jn0Py8r6rNUy4FGe-APJTgXiIKNKejvmHAozbWYvgu0h4-g60HREHeGhQHcJqwjW0JE7gYBV8tftbOIHPHE6jmq-JKoCbwNQB-ZRw7ju7iJtPE_tVRVkfAloQhL4n4PrF9WPx5ez08v2HaDORITJ5mS4jbVCnDrPa1TqW0mHtjMsr1CitNQ6rNHGImMVWI1KkolwmZaLSslamkphkT8RBN-3sMwGZcWQsKisTjWRHEp2mCebk_2FsrHJlTwyu5dOYDVw5T80YNxS2sEQbL9GGJdp4ifbEm-0bswDV8RfadyzyLR2DbPsbpHrNRvWaf6leT7y6VpiGNiVnWlRnp6tFk3D6MmOstJ54GhRo-6lUloy-mvaE3FOtPV72n3TtlQf-LjgxVpSH_4P55-IuL4cvl5MvxMFyvrIvxR3zbdku5kfithxVR35P0fX8x-kvUIIt7g |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pathway+Markers+for+Pro-resolving+Lipid+Mediators+in+Maternal+and+Umbilical+Cord+Blood%3A+A+Secondary+Analysis+of+the+Mothers%2C+Omega-3%2C+and+Mental+Health+Study&rft.jtitle=Frontiers+in+pharmacology&rft.au=Mozurkewich%2C+Ellen+L.&rft.au=Greenwood%2C+Matthew&rft.au=Clinton%2C+Chelsea&rft.au=Berman%2C+Deborah&rft.date=2016-09-07&rft.pub=Frontiers+Media+S.A&rft.eissn=1663-9812&rft.volume=7&rft_id=info:doi/10.3389%2Ffphar.2016.00274&rft_id=info%3Apmid%2F27656142&rft.externalDocID=PMC5013256 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1663-9812&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1663-9812&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1663-9812&client=summon |